Evidence map›Paper›PMID 36324020›Full record

ArticleAmbio2023

The European Commission's Green Deal is an opportunity to rethink harmful practices of research and innovation policy.

Michael J Bernstein, Thomas Franssen, Robert D J Smith, Mandy de Wilde

Open access · hybridAbstract read
In one paragraph

Article in Ambio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 13 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Michael J BernsteinCenter for Innovation Systems & Policy, AIT Austrian Institute of Technology GmbH, Giefinggasse 4, 1210, Vienna, Austria. michael.bernstein@ait.ac.at.ORCID http://orcid.org/0000-0001-7980-0489
Thomas Franssen *Centre for Science and Technology Studies, Leiden University, P.O. Box 905, 2300 AX, Leiden, The Netherlands.
Robert D J Smith *Chisholm House, High School Yards, Edinburgh, EH1 1LZ, UK.
Mandy de Wilde *University of Amsterdam, Postbus 15509, 1001 NA, Amsterdam, The Netherlands.
Austrian Institute of Technology · ATLeiden University · NLUniversity of Amsterdam · NL

Funding

Horizon 2020 Framework Programme 722361
6 · The paper itself

Abstract

The European Union's Green Deal and associated policies, aspiring to long-term environmental sustainability, now require economic activities to 'do no significant harm' to EU environmental objectives. The way the European Commission is enacting the do no significant harm principle relies on quantitative tools that try to identify harm and adjudicate its significance. A reliance on established technical approaches to assessing such questions ignores the high levels of imprecision, ambiguity, and uncertainty-levels often in flux-characterizing the social contexts in which harms emerge. Indeed, harm, and its significance, are relational, not absolute. A better approach would thus be to acknowledge the relational nature of harm and develop broad capabilities to engage and 'stay with' the harm. We use the case of European research and innovation activities to expose the relational nature of harm, and explore an alternative and potentially more productive approach that departs from attempts to unilaterally or uniformly claim to know or adjudicate what is or is not significantly harmful. In closing, we outline three ways research and innovation policy-makers might experiment with reconfiguring scientific and technological systems and practices to better address the significant harms borne by people, other-than-human beings, and ecosystems.

Indexed as

EcosystemPolicyHumansTechnologyDo no significant harmEuropean Green DealFeminist science policyResearch policySituated ethicsSustainability

Identifiers

PMID36324020
PMCPMC9849660
OpenAlexW4308058548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.